Does Raloxifene Hydrochloride Interact with Cholestyramine Light?
CDI records a major classification for Raloxifene Hydrochloride and Cholestyramine Light. The stored summary is: Reduces absorption and enterohepatic cycling of raloxifene by 60%. Concomitant use is not recommended. The mechanism involves anion exchange resin reduces raloxifene absorption and enterohepatic cycling. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Cholestyramine Light Class
- Bile Acid Sequestrant
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Anion exchange resin reduces raloxifene absorption and enterohepatic cycling
What To Tell Your Doctor or Pharmacist
If you are taking Raloxifene Hydrochloride and your doctor is considering prescribing Cholestyramine Light (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider